Skip to main content
. 2021 May 29;3(3):fcab121. doi: 10.1093/braincomms/fcab121

Figure 3.

Figure 3

CSF catecholamine levels in hip fracture patients with and without pre-fracture dementia. (A) Hip fracture patients with pre-fracture dementia (n = 60) did compared to those with no pre-fracture dementia (n = 58) not have statistically significant lower CSF noradrenaline levels (P = 0.17) but had significantly lower CSF levels of (B) adrenaline and (C) dopamine. Larger and smaller lines represent median and interquartile range respectively. Two-tailed P-values are obtained by Mann–Whitney U-test.